SL
Silence Ther
SLN.L·LSELondon UKFounded 2012100 employees
Small CapbiotechPublicCardiologyHematology
Platform: SiRNA GalNAc
Market Cap
$0.4B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (SLN.L)
Loading SLN.L stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SLN-495 | SLN-495 | Phase 1 | 1 | GPRC5D | RCC | ||
| Capicilimab | SLN-3021 | Phase 2/3 | 1 | MET | NSCLCHNSCC |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Silence Ther trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)